Carnegie Investment Counsel boosted its position in The Allstate Co. (NYSE:ALL - Free Report) by 116.9% in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 2,562 shares of the insurance provider's stock after purchasing an additional 1,381 shares during the quarter. Carnegie Investment Counsel's holdings in Allstate were worth $494,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Pathway Financial Advisers LLC increased its holdings in shares of Allstate by 18,472.5% in the third quarter. Pathway Financial Advisers LLC now owns 1,052,687 shares of the insurance provider's stock valued at $199,642,000 after purchasing an additional 1,047,019 shares during the last quarter. Allspring Global Investments Holdings LLC raised its holdings in shares of Allstate by 18.7% during the 3rd quarter. Allspring Global Investments Holdings LLC now owns 3,000,866 shares of the insurance provider's stock worth $569,114,000 after acquiring an additional 472,040 shares during the period. AQR Capital Management LLC boosted its position in shares of Allstate by 181.6% during the 2nd quarter. AQR Capital Management LLC now owns 719,997 shares of the insurance provider's stock valued at $114,955,000 after acquiring an additional 464,337 shares during the last quarter. TimesSquare Capital Management LLC purchased a new stake in shares of Allstate in the third quarter valued at about $77,819,000. Finally, Los Angeles Capital Management LLC increased its position in Allstate by 688.4% during the third quarter. Los Angeles Capital Management LLC now owns 460,282 shares of the insurance provider's stock worth $87,292,000 after purchasing an additional 401,901 shares during the last quarter. Hedge funds and other institutional investors own 76.47% of the company's stock.
Several analysts have recently weighed in on the stock. The Goldman Sachs Group increased their price target on shares of Allstate from $209.00 to $230.00 and gave the company a "buy" rating in a research note on Friday, November 15th. JPMorgan Chase & Co. raised their target price on Allstate from $205.00 to $207.00 and gave the stock an "overweight" rating in a research note on Thursday, October 10th. Keefe, Bruyette & Woods upped their price target on Allstate from $235.00 to $243.00 and gave the company an "outperform" rating in a research note on Friday, January 10th. Jefferies Financial Group increased their price target on Allstate from $231.00 to $267.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, UBS Group boosted their price objective on shares of Allstate from $216.00 to $225.00 and gave the company a "buy" rating in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat.com, Allstate presently has an average rating of "Moderate Buy" and an average target price of $218.13.
View Our Latest Analysis on ALL
Shares of NYSE:ALL traded down $2.25 during trading hours on Friday, reaching $188.85. The stock had a trading volume of 1,518,986 shares, compared to its average volume of 1,271,858. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The firm's 50 day moving average is $195.73 and its 200-day moving average is $186.32. The stock has a market capitalization of $50.01 billion, a price-to-earnings ratio of 12.23, a P/E/G ratio of 1.35 and a beta of 0.52. The Allstate Co. has a 1 year low of $150.17 and a 1 year high of $209.88.
Allstate (NYSE:ALL - Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $3.91 earnings per share for the quarter, topping the consensus estimate of $2.20 by $1.71. Allstate had a net margin of 6.77% and a return on equity of 26.67%. The business had revenue of $16.63 billion during the quarter, compared to the consensus estimate of $14.57 billion. During the same quarter in the previous year, the firm earned $0.81 EPS. The company's revenue was up 14.7% compared to the same quarter last year. Research analysts predict that The Allstate Co. will post 16.45 earnings per share for the current fiscal year.
The company also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Shareholders of record on Friday, November 29th were paid a $0.92 dividend. This represents a $3.68 dividend on an annualized basis and a yield of 1.95%. The ex-dividend date was Friday, November 29th. Allstate's dividend payout ratio is currently 23.83%.
The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.
Before you consider Allstate, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Allstate wasn't on the list.
While Allstate currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.